Analystreport

Zosano Pharma Co. (NASDAQ: ZSAN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.

Zosano Pharma Corporation  (ZSAN) 
Last zosano pharma corporation earnings: 11/9 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.zosanopharma.com